DEFINITIVE PROXY STATEMENT

Company

ORAMED PHARMACEUTICALS INC.

Filed

May 31, 2023

Period of Report

July 13, 2023

Accession Number

0001213900-23-044530

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →